Welcome to the CCBIO seminar series in the spring term of 2025. Open to all in auditorium 4, BBB. No registration necessary. Speaker is Stein-Erik Gullaksen from CCBIO/UiB, on the topic "Deep single cell immune and signaling profiling hours after starting treatment predict response to treatment in patients with Chronic myeloid leukemia." Read more on LES MER
Er du nysgjerrig på gründerskap og innovasjon? Vil du bli inspirert av en ekspert på fagfeltet? Foredragsholder: Sjur Dagestad Tid: 19. Mai 2025 kl 14.00-14.45 Sted: Birkhaugssalen, Sentralblokken, HUS Sjur Dagestad vil ta oss med på en liten rundreise innen faget innovasjon. Sjur har jobbet med innovasjon siden 1988, både som gründer, leder og professor. LES MER
Program/saksliste 1700-1730: «Generell informasjon om brukermedvirkning» med Merete Eide Hernes og Trude Hjortland Fra Seksjon for samhandling, Helse Bergen 1730-1745: «Dendrittcellevaksine ved KML» ved Morten Yong Isaksen 1745-1800: «The Hovon 135 study : a Single cell approach» ved Oriol Castell 1800-1810: Pause 1810-1830: Brukerutvalgets rolle og mandat i C-MYC ved LES MER
Stine Haugstvedt will present and defend her Master's thesis: “Optimizing single-cell and immune profiling of asciminib-treated chronic myeloid leukemia patients using mass cytometry” Date: Thursday, August 21 Time: 10:15 AM Location: Birkhaugsalen, D305, 3rd floor, Central Block, Haukeland University Hospital Supervisors: Assoc. Prof. Morten Beck Rye (NTNU) Prof. Bjørn Tore Gjertsen (UiB) Dr. Stein-Erik Gullaksen (UiB) Internal Examiner: Prof. LES MER
13:00 –Assoc. Prof. Morten Rye, Dept. of Clinical and Molecular Medicine, NTNU: Spatial Transcriptomics Analysis of Prostate Cancer The cancerous prostate gland is a heterogenous mix of different cancer and normal cells and tissue types, which is a major source of confounding when large scale molecular - omics analysis is performed on the prostate gland. LES MER
We are delighted to invite you to Bergen, Norway, for the upcoming Nordic AML Meeting, taking place in September 10-12, 2025. Set against the breathtaking backdrop of Bergen’s stunning fjords and vibrant cultural heritage, this event will bring together leading minds, practitioners, and innovators in the field of AML. It is an unparalleled opportunity to LES MER
ESH-iCMLf 27th Annual John Goldman Conference on Chronic Myeloid Leukemia: Biology and Therapy Estoril, Portugal - #ESHCML2025 Presentations by CMYC participants at the conferences
7th International Conference: Acute Myeloid Leukemia "Molecular and Translational": Advances in Biology and Treatment Estoril, Portugal Presentations by CMYC participants at the conferences
Welcome to the upcoming seminar holdt by Professor Ole Morten Seternes, Group Leader of the Cell Signalling and Targeted Therapy Research Group, Department of Pharmacy, UIT The Arctic University of Norway. Tittle: The dual specificity MAP kinase phosphatase DUSP2 acts as distal regulatory node in T Cell signalling Time: 22nd October 2025. 14:00 - 15:00 LES MER
"Stress for success”: Unlocking Venetoclax sensitivity in T-ALL through the mTORC1–ISR–BMF axis. by Prof. Vincenzo Ciminale, MD, Istituto Oncologico Veneto, Padova, Italy When: Thursday, 13.11.2025, 14.30–15.30 Where: Aud. 4, BBB Host: Bjørn Tore Gjertsen Abstract Refractory/relapsed T-cell acute lymphoblastic leukemia (R/R T-ALL) remains a major therapeutic challenge at present. Our recent studies showed that inhibition of mTORC1 markedly sensitizes LES MER
Tara Helén Steinsland Dowling is presenting and defending for ph.d.-degree with her thesis "Acute myeloid leukemia at single-cell resolution: Clonal heterogeneity in precision therapy" Trial lecture: "Relevance of clonal hematopoiesis in hematological malignancies" Time: 10.15–11.00 Place: HUS - BB-bygget, Auditorium 2 Defense Time: 12.15–15.00 Location: HUS - BB-bygget, Auditorium 2 For more information: https://www.uib.no/nye-doktorgrader/180253/krigen-mellom-klonane-det-klonale-landskapet-i-aml
EN